Skip to content

Bone HealthBone Health

This category covers medicines that strengthen bone and correct calcium or vitamin D shortfalls, mainly to prevent fractures in osteoporosis. Treatment is usually long term and combines a bone-protecting medicine with correction of the calcium and vitamin D that support it.

Fosamax

Alendronic Acid

35 · 70mg

Alendronic acid 35mg and 70mg tablets, the weekly strengths, used in the management of osteoporosis. A bisphosphonate that slows bone resorption.

From$2.55/ tabletView

Raloxifene Tablets

Raloxifene

60mg

Raloxifene 60mg film-coated tablets, used in the management of osteoporosis. A SERM that acts like oestrogen on bone but not on breast tissue.

From$1.02/ tabletView

Alfacip

Alfacalcidol

0.25 · 0.5mcg

Alfacip is alfacalcidol in 0.25mcg and 0.5mcg soft capsules, used for rickets, osteomalacia and hypoparathyroidism. A vitamin D analogue activated in the liver.

From$0.62/ capsuleView

Rocaltrol

Calcitriol

0.25mg

Calcitriol 0.25mg capsules, used in the management of renal osteodystrophy and hypocalcaemia. The active form of vitamin D3, needing no conversion.

From$2.00/ capsuleView

Phoslo

Calcium Acetate

667mg

Calcium acetate 667mg tablets, used in the management of hyperphosphataemia. A phosphate binder that ties up dietary phosphate in the gut.

From$0.51/ tabletView

One-alpha

Alfacalcidol

0.25mcg

Alfacalcidol 0.25mcg soft capsules and oral drops, used in the management of osteomalacia, hyperparathyroidism and hypocalcaemia. A vitamin D analogue.

From$0.62/ capsuleView

Key points

  • The aim is fracture prevention, which is why treatment continues without any obvious day-to-day effect.
  • Bisphosphonates slow bone loss, while vitamin D and calcium correct the shortfalls that undermine it.
  • How a bisphosphonate is taken, upright and away from food, changes how much is absorbed.

Classes and ingredients in this category

Conditions it covers

These medicines are used for osteoporosis, osteomalacia and hypocalcaemia. Bone density, fracture history and calcium status decide the regimen, which is reviewed rather than continued indefinitely.

Further reading